A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD

Acute exacerbations of chronic obstructive pulmonary disease (COPD), an acute worsening of respiratory symptoms, generally result in a poor prognosis. Successful prevention and management of such exacerbations is thus important for patient care. Viral infection, primarily with rhinovirus (RV), is th...

Full description

Bibliographic Details
Main Authors: Takahiko Sasaki, Katsutoshi Nakayama, Hiroyasu Yasuda, Mutsuo Yamaya
Format: Article
Language:English
Published: SAGE Publishing 2011-04-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753465810392264
_version_ 1818056779862376448
author Takahiko Sasaki
Katsutoshi Nakayama
Hiroyasu Yasuda
Mutsuo Yamaya
author_facet Takahiko Sasaki
Katsutoshi Nakayama
Hiroyasu Yasuda
Mutsuo Yamaya
author_sort Takahiko Sasaki
collection DOAJ
description Acute exacerbations of chronic obstructive pulmonary disease (COPD), an acute worsening of respiratory symptoms, generally result in a poor prognosis. Successful prevention and management of such exacerbations is thus important for patient care. Viral infection, primarily with rhinovirus (RV), is the foremost cause of exacerbations in COPD patients. Proton pump inhibitors (PPIs) have been reported to inhibit RV infection in human airway epithelial cells in vitro . Furthermore, clinical trials of PPIs in patients with COPD resulted in a reduction in rates of both common cold and COPD exacerbations. In this review, we discuss the significance of COPD exacerbations, summarize a published trial of the effect of low-dose PPIs on COPD exacerbations, and postulate a mechanism for this effect.
first_indexed 2024-12-10T12:34:16Z
format Article
id doaj.art-8e8da1af486642979df85546eb0c5a22
institution Directory Open Access Journal
issn 1753-4658
1753-4666
language English
last_indexed 2024-12-10T12:34:16Z
publishDate 2011-04-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Respiratory Disease
spelling doaj.art-8e8da1af486642979df85546eb0c5a222022-12-22T01:48:43ZengSAGE PublishingTherapeutic Advances in Respiratory Disease1753-46581753-46662011-04-01510.1177/1753465810392264A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPDTakahiko SasakiKatsutoshi NakayamaHiroyasu YasudaMutsuo YamayaAcute exacerbations of chronic obstructive pulmonary disease (COPD), an acute worsening of respiratory symptoms, generally result in a poor prognosis. Successful prevention and management of such exacerbations is thus important for patient care. Viral infection, primarily with rhinovirus (RV), is the foremost cause of exacerbations in COPD patients. Proton pump inhibitors (PPIs) have been reported to inhibit RV infection in human airway epithelial cells in vitro . Furthermore, clinical trials of PPIs in patients with COPD resulted in a reduction in rates of both common cold and COPD exacerbations. In this review, we discuss the significance of COPD exacerbations, summarize a published trial of the effect of low-dose PPIs on COPD exacerbations, and postulate a mechanism for this effect.https://doi.org/10.1177/1753465810392264
spellingShingle Takahiko Sasaki
Katsutoshi Nakayama
Hiroyasu Yasuda
Mutsuo Yamaya
A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
Therapeutic Advances in Respiratory Disease
title A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
title_full A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
title_fullStr A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
title_full_unstemmed A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
title_short A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD
title_sort new strategy with proton pump inhibitors for the prevention of acute exacerbations in copd
url https://doi.org/10.1177/1753465810392264
work_keys_str_mv AT takahikosasaki anewstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd
AT katsutoshinakayama anewstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd
AT hiroyasuyasuda anewstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd
AT mutsuoyamaya anewstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd
AT takahikosasaki newstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd
AT katsutoshinakayama newstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd
AT hiroyasuyasuda newstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd
AT mutsuoyamaya newstrategywithprotonpumpinhibitorsforthepreventionofacuteexacerbationsincopd